RAP 0.00% 20.5¢ resapp health limited

Ann: Results from Data Confirmation Study, page-11

  1. 297 Posts.
    lightbulb Created with Sketch. 524
    Data confirmation study results significantly lower than previously reported - but the BOD and TK still recommend the much lower offer by Pfizer.

    Good luck to all holders and I feel bad for you - looks like RAP's BOD has sold out and their interests are no longer aligned with the SHs and they don't care if many SHs get burned.

    Unbelievable.

    GLTAH and DYOR

 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.